GlaxoSmithKline Pharmaceuticals informs about loss of share certificate

08 May 2024 Evaluate

Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Regulations’), GlaxoSmithKline Pharmaceuticals has informed that Registrar and Transfer Agent of Company - KFin Technologies has received request for issue of duplicate Share Certificates from Shareholders, Hemant Kumar Bhansaly & Meena Poladia further details enclosed. The company will issue the Letter of Confirmation only after the necessary formalities are carried out by the Shareholders.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2630.60 37.60 (1.45%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.